3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Renal Cell
23
Kidney Neoplasms
10
Neoplasms
8
Carcinoma, Non-Small-Cell Lung
7
Carcinoma
6
Melanoma
4
Lung Neoplasms
4
Colorectal Neoplasms
4
Neoplasm Metastasis
3
Carcinoma, Hepatocellular
3
Thyroid Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Kidney Diseases
2
Clear-cell metastatic renal cell carcinoma
2
Carcinoma, Adenoid Cystic
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uveal Melanoma
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Solid Tumors
1
Skin Neoplasms
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Recurrence
1
Prostatic Neoplasms
1
Pheochromocytoma
1
Paraganglioma
1
Interventions
pembrolizumab
8
Nivolumab
5
avelumab
4
Ipilimumab
4
Radiotherapy
2
Radiosurgery
2
ALT-803
2
tremelimumab
1
talimogene laherparepvec
1
sapanisertib
1
prednylidene
1
poly ICLC
1
lenvatinib
1
interferon gamma-1b
1
epacadostat
1
efineptakin alfa
1
durvalumab
1
deltacortene
1
cemiplimab
1
cabozantinib
1
bempegaldesleukin
1
atezolizumab
1
Tacrolimus
1
Radiation Dose Hypofractionation
1
Radiation
1
Prednisone
1
Interferon-gamma
1
Interferon-beta
1
CTLA-4 Antigen
1
B7-H1 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Merkel Cell
×
Axitinib
×
Clear all
No trials found.